Clarkston Capital Partners’s CVS Health CVS Stock Holding History

Clarkston Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,377	Closed	-$501K	–	169
2022 Q4	$501K	Sell	5,377 -92	-2%	-$8.88K	0.01%	118
2022 Q3	$522K	Sell	5,469 -590	-10%	-$58.4K	0.01%	119
2022 Q2	$561K	Sell	6,059 -325	-5%	-$31.7K	0.01%	117
2022 Q1	$646K	Sell	6,384 -2,380	-27%	-$250K	0.01%	122
2021 Q4	$904K	Sell	8,764 -1,100	-11%	-$102K	0.02%	96
2021 Q3	$837K	Sell	9,864 -1,175	-11%	-$98.4K	0.02%	86
2021 Q2	$921K	Sell	11,039 -315	-3%	-$25.8K	0.02%	85
2021 Q1	$854K	Buy	+11,354	New	+$827K	0.02%	85
2020 Q2	–	Sell	-4,012	Closed	-$238K	–	115
2020 Q1	$238K	Buy	+4,012	New	+$268K	0.01%	87
2017 Q2	–	Sell	-2,612	Closed	-$205K	–	97
2017 Q1	$205K	Sell	2,612 -100	-4%	-$7.98K	0.01%	94
2016 Q4	$214K	Hold	2,712	–	–	0.01%	113
2016 Q3	$241K	Hold	2,712	–	–	0.01%	113
2016 Q2	$260K	Sell	2,712 -25	-0.9%	-$2.49K	0.01%	111
2016 Q1	$284K	Sell	2,737 -1,563	-36%	-$152K	0.02%	113
2015 Q4	$420K	Buy	+4,300	New	+$421K	0.03%	102

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Clarkston Capital Partners's CVS Position: Q1 2023 in Review

Clarkston Capital Partners sold out of CVS Health (CVS) in Q1 2023, closing a stake of 5,377 shares — an estimated $501K sold.

Clarkston Capital Partners first reported a position in CVS in Q4 2015 and held it in 15 quarters. The position peaked at $921K in Q2 2021. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

Clarkston Capital Partners reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
Clarkston Capital Partners sold 5,377 CVS Health shares in Q1 2023, an estimated $501K.
Clarkston Capital Partners first reported a position in CVS Health in Q4 2015 and held it in 15 quarters.
Clarkston Capital Partners's CVS Health position peaked at $921K in Q2 2021.
2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Clarkston Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.